NCT00217880View on ClinicalTrials.gov

Significance of Biological Markers in Patients With Acute Lung Injury/Acute Respiratory Disease

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

April 30, 2009

Study Completion Date

June 30, 2009

Conditions
Respiratory Distress Syndrome, Adult
Interventions
PROCEDURE

Bronchoscopy

A bronchoscopy test will occur to view the participant's airways.

Trial Locations (2)

30322

Emory University, Atlanta

48109

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Michigan

OTHER

NCT00217880 - Significance of Biological Markers in Patients With Acute Lung Injury/Acute Respiratory Disease | Biotech Hunter | Biotech Hunter